SURI Holdings — Simplify Propel Opportunities ETF
All 36 reported holdings of Simplify Propel Opportunities ETF (SURI) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| United States Of America - Bureau Of The Public Debt | 76.77% | $59.30M |
| Plains Gp Holdings LP | 39.97% | $30.88M |
| Achieve Life Sciences, Inc. | 12.11% | $9.35M |
| Milestone Pharmaceuticals, Inc. | 5.81% | $4.49M |
| Achieve Life Sciences, Inc. | 4.42% | $3.41M |
| Delcath Systems, Inc. | 4.26% | $3.29M |
| Phathom Pharmaceuticals, Inc. | 3.50% | $2.70M |
| Corcept Therapeutics, Inc. | 2.98% | $2.30M |
| Abeona Therapeutics, Inc. | 2.76% | $2.13M |
| Celldex Therapeutics, Inc. | 2.56% | $1.98M |
| Kyverna Therapeutics, Inc. | 2.11% | $1.63M |
| Compass Pathways PLC | 2.09% | $1.62M |
| Leonabio, Inc. | 1.78% | $1.37M |
| Inventiva SA | 1.53% | $1.18M |
| Aquestive Therapeutics, Inc. | 1.50% | $1.16M |
| Artiva Biotherapeutics, Inc. | 1.27% | $983.14K |
| Zevra Therapeutics, Inc. | 1.25% | $966.11K |
| Orchestra Biomed Holdings, Inc. | 1.23% | $946.65K |
| Palisade Bio, Inc. | 1.22% | $941.63K |
| Telesat Canada / Telesat LLC | 1.16% | $895.00K |
| Ocular Therapeutix, Inc. | 1.03% | $795.92K |
| Achieve Life Scien Rts | 0.97% | $747.73K |
| Eyepoint, Inc. | 0.84% | $649.35K |
| Immunic, Inc. | 0.61% | $472.24K |
| Upstream Bio, Inc. | 0.56% | $429.82K |
| Akero Therapeutics Inc | 0.55% | $426.63K |
| Sab Biotherapeutics, Inc. | 0.53% | $408.91K |
| Ovid Therapeutics, Inc. | 0.34% | $260.44K |
| Altimmune, Inc. | 0.00% | $3.16K |
| Chinook Therapeutics, Inc. | 0.00% | $2.00K |
| Eiger BioPharmaceuticals Inc | 0.00% | $900 |
| Quoin Pharmaceutic Wts | 0.00% | $0 |
| Jasper Therapeutic Wts | 0.00% | $1 |
| Milestone Pharmace Wts | 0.00% | $2 |
| Wts - Tenaya Therapeutics | 0.00% | $1 |
| Morgan Stanley & Co. LLC | -75.22% | $-58.11M |
SURI overview: performance, fees, allocation and SEC filings